You are here: Industry Insights > ICMRA

News List

NMPA Deputy Commissioner participates in ICMRA’s 2021 online summit NMPA
December 06, 2021
Other participants included related officials from the NMPA's Department of Science, Technology and International Cooperation, Department of Drug Registration, Department of Drug Regulation...
ICMRA and WHO state clinical trial reports should be published without redaction europeanpharmaceuticalreview
May 11, 2021
The International Coalition of Medicines Regulatory Authorities (ICMRA) and WHO are calling on pharma to provide voluntary unrestricted access to trial results data.
International regulators align positions on phase 3 COVID-19 vaccine trials expresspharma
July 13, 2020
The meeting participants stressed the need for large phase 3 clinical trials that enroll many thousands of people, including those with underlying medical conditions, to generate relevant data for the key target populations.
Safe and effective vaccination should be given high priority: EMA expresspharma
June 19, 2020
The two ICMRA statements aim to reassure healthcare professionals and the public around the globe that medicines regulators only allow vaccines onto the market that fulfil the highest standards of safety, efficacy and quality.
Global regulatory authorities COVID-19 policy and regulations meeting europeanpharmaceuticalreview
June 04, 2020
Global pharma regulators met to discuss measures to ensure supply continuity, flexible regulatory policies and their expectations for COVID-19 clinical trials.
ICMRA to discuss alignment on policy approaches and regulatory flexibility during COVID-19 expresspharma
May 20, 2020
The strategic meeting underlined the need and commitment by global regulators to cooperate and align their approaches to clinical trial management, medicine supply issues and pharmacovigilance in light of the medical emergency presented by COVID-19.